top of page
gradientForSurfBreak.png

Item List

SpinalNews International
COMPaSS personalised spine surgery study begins enrolment

Carlsmed has revealed that the first patients have been enrolled in the COMPaSS study, a multicentre post market prospective observational registry which will collect data up to two years on patients with degenerative spinal conditions who are treated surgically with the company’s aprevo devices.

Recent Posts

Wavemaker 360 News

Carlsmed.png

Episode 108: Jay Goss, General Partner at Wavemaker Three-Sixty Health ...

MedTech Money

Portfolio Company

Carlsmed.png

Strados Labs forms collaboration with Boehringer Ingelheim for its Idiopathic Pu ...

Cision PR Newsire

Portfolio Company

Carlsmed.png

Caduceus Capital Partners, Wavemaker Three-Sixty Health Co-Lead Series A Investm ...

Businesswire

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page